Congress / Branded Pharmaceutical Association / Food and Drug Administration / Division of Dockets Management / Committee on Appropriations / US Federal Reserve / House Committee / HAND-DELIVERED Division of Dockets Management / Center for Drug Evaluation / Committee on Health / Education / Labor / and Pensionsregarding / Senate / /
Person
D. BROOKS RYAN / BRETT T. SCHWEMER FRANKAND WEEDA / MARSHALL L. MATZ MICHAEL / JOHN W. BODE / PHILIP C. OLSSON RICHARD / FLAHERTY DAVID / STEPHEN D. TERMAN MARSHALL / DENNIS R JOHNSON / RYAN W. STROSCHEIN EVAN / RICHARD L. FRANK / FLAHERTY PAMELA J FURMAN / VALERIE B. SOLOMON / C. TISH E PAHL ROBERT / L. FRANK DAVID E WEEDA / PAMELA J FURMAN BRETT / ARTHUR Y. TSIEN JOHN / DAVID L. DURKIN NEIL / SHARON D. BROOKS / JOHNSON ARTHUR / L. LACEY SHARON / ROBERT A HAHN NAOMI / / /
Position
LCDurkin Counsel / COUNSEL / Director / /
Product
digoxin / levothyroxine sodium / PRESCRIPTION DRUG / New Drug / 02P-0483 / /